TrialInvestigational new drugs2018

Phase II trial of ifosfamide in combination with the VEGFR inhibitor sorafenib in advanced soft tissue sarcoma: a Spanish group for research on sarcomas (GEIS) study.

Xavier García Del Muro et al.PubMed ↗Publisher ↗

No numbers read from the abstract.